3.26.1 html 293 257 1 false 89 0 false 6 false false R1.htm 75000 - Document - Cover Page Sheet http://karyopharm.com/20260630/taxonomy/role/CoverPage Cover Page Cover 1 false false R2.htm 75010 - Statement - Condensed Consolidated Balance Sheets (unaudited) Sheet http://karyopharm.com/20260630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited Condensed Consolidated Balance Sheets (unaudited) Statements 2 false false R3.htm 75020 - Statement - Condensed Consolidated Balance Sheets (unaudited) (Parenthetical) Sheet http://karyopharm.com/20260630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical Condensed Consolidated Balance Sheets (unaudited) (Parenthetical) Statements 3 false false R4.htm 75030 - Statement - Condensed Consolidated Statements of Operations (unaudited) Sheet http://karyopharm.com/20260630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited Condensed Consolidated Statements of Operations (unaudited) Statements 4 false false R5.htm 75040 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss) Sheet http://karyopharm.com/20260630/taxonomy/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncomeLoss Condensed Consolidated Statements of Comprehensive Income (Loss) Statements 5 false false R6.htm 75050 - Statement - Condensed Consolidated Statements of Cash Flows (unaudited) Sheet http://karyopharm.com/20260630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited Condensed Consolidated Statements of Cash Flows (unaudited) Statements 6 false false R7.htm 75080 - Statement - Condensed Consolidated Statements of Stockholders' Deficit (unaudited) Sheet http://karyopharm.com/20260630/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficitUnaudited Condensed Consolidated Statements of Stockholders' Deficit (unaudited) Statements 7 false false R8.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 8 false false R9.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 9 false false R10.htm 995455 - Disclosure - Nature of Business, Basis of Presentation and Segment Information Sheet http://karyopharm.com/20260630/taxonomy/role/DisclosureNatureOfBusinessBasisOfPresentationAndSegmentInformation1 Nature of Business, Basis of Presentation and Segment Information Notes 10 false false R11.htm 995465 - Disclosure - Product Revenue Sheet http://karyopharm.com/20260630/taxonomy/role/ProductRevenue Product Revenue Notes 11 false false R12.htm 995475 - Disclosure - Inventory Sheet http://karyopharm.com/20260630/taxonomy/role/Inventory Inventory Notes 12 false false R13.htm 995485 - Disclosure - License Agreements Sheet http://karyopharm.com/20260630/taxonomy/role/DisclosureLicenseAgreements License Agreements Notes 13 false false R14.htm 995495 - Disclosure - Fair Value Measurements Sheet http://karyopharm.com/20260630/taxonomy/role/DisclosureFairValueMeasurements Fair Value Measurements Notes 14 false false R15.htm 995505 - Disclosure - Investments Sheet http://karyopharm.com/20260630/taxonomy/role/Investments Investments Notes 15 false false R16.htm 995515 - Disclosure - Net Loss Per Share Sheet http://karyopharm.com/20260630/taxonomy/role/DisclosureNetLossPerShare1 Net Loss Per Share Notes 16 false false R17.htm 995525 - Disclosure - Stock-based Compensation Expense Sheet http://karyopharm.com/20260630/taxonomy/role/DisclosureStockbasedCompensationExpense Stock-based Compensation Expense Notes 17 false false R18.htm 995535 - Disclosure - Stockholders' Equity Sheet http://karyopharm.com/20260630/taxonomy/role/DisclosureStockholdersEquity Stockholders' Equity Notes 18 false false R19.htm 995545 - Disclosure - Long-Term Obligations Sheet http://karyopharm.com/20260630/taxonomy/role/DisclosureLongtermObligations1 Long-Term Obligations Notes 19 false false R20.htm 995555 - Disclosure - Common Share Warrants Sheet http://karyopharm.com/20260630/taxonomy/role/DisclosureCommonShareWarrants Common Share Warrants Notes 20 false false R21.htm 995575 - Disclosure - Nature of Business, Basis of Presentation and Segment Information (Policies) Sheet http://karyopharm.com/20260630/taxonomy/role/DisclosureNatureOfBusinessBasisOfPresentationAndSegmentInformationPolicies Nature of Business, Basis of Presentation and Segment Information (Policies) Policies 21 false false R22.htm 995585 - Disclosure - Nature of Business, Basis of Presentation and Segment Information (Tables) Sheet http://karyopharm.com/20260630/taxonomy/role/DisclosureNatureOfBusinessBasisOfPresentationAndSegmentInformationTables Nature of Business, Basis of Presentation and Segment Information (Tables) Tables http://karyopharm.com/20260630/taxonomy/role/DisclosureNatureOfBusinessBasisOfPresentationAndSegmentInformation1 22 false false R23.htm 995595 - Disclosure - Product Revenue (Tables) Sheet http://karyopharm.com/20260630/taxonomy/role/ProductRevenueTables Product Revenue (Tables) Tables http://karyopharm.com/20260630/taxonomy/role/ProductRevenue 23 false false R24.htm 995605 - Disclosure - Inventory (Tables) Sheet http://karyopharm.com/20260630/taxonomy/role/InventoryTables Inventory (Tables) Tables http://karyopharm.com/20260630/taxonomy/role/Inventory 24 false false R25.htm 995615 - Disclosure - License Agreements (Tables) Sheet http://karyopharm.com/20260630/taxonomy/role/DisclosureLicenseAgreementsTables License Agreements (Tables) Tables http://karyopharm.com/20260630/taxonomy/role/DisclosureLicenseAgreements 25 false false R26.htm 995625 - Disclosure - Fair Value Measurements (Tables) Sheet http://karyopharm.com/20260630/taxonomy/role/DisclosureFairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://karyopharm.com/20260630/taxonomy/role/DisclosureFairValueMeasurements 26 false false R27.htm 995635 - Disclosure - Investments (Tables) Sheet http://karyopharm.com/20260630/taxonomy/role/InvestmentsTables Investments (Tables) Tables http://karyopharm.com/20260630/taxonomy/role/Investments 27 false false R28.htm 995645 - Disclosure - Net Loss Per Share (Tables) Sheet http://karyopharm.com/20260630/taxonomy/role/DisclosureNetLossPerShareTables Net Loss Per Share (Tables) Tables http://karyopharm.com/20260630/taxonomy/role/DisclosureNetLossPerShare1 28 false false R29.htm 995655 - Disclosure - Stock-based Compensation Expense (Tables) Sheet http://karyopharm.com/20260630/taxonomy/role/DisclosureStockbasedCompensationExpenseTables Stock-based Compensation Expense (Tables) Tables http://karyopharm.com/20260630/taxonomy/role/DisclosureStockbasedCompensationExpense 29 false false R30.htm 995665 - Disclosure - Long-Term Obligations (Tables) Sheet http://karyopharm.com/20260630/taxonomy/role/DisclosureLongtermObligationsTables Long-Term Obligations (Tables) Tables http://karyopharm.com/20260630/taxonomy/role/DisclosureLongtermObligations1 30 false false R31.htm 995675 - Disclosure - Common Share Warrants (Tables) Sheet http://karyopharm.com/20260630/taxonomy/role/DisclosureCommonShareWarrantsTables Common Share Warrants (Tables) Tables http://karyopharm.com/20260630/taxonomy/role/DisclosureCommonShareWarrants 31 false false R32.htm 995685 - Disclosure - Nature of Business, Basis of Presentation and Segment Information (Detail) Sheet http://karyopharm.com/20260630/taxonomy/role/DisclosureNatureOfBusinessBasisOfPresentationAndSegmentInformationDetail Nature of Business, Basis of Presentation and Segment Information (Detail) Details http://karyopharm.com/20260630/taxonomy/role/DisclosureNatureOfBusinessBasisOfPresentationAndSegmentInformationTables 32 false false R33.htm 995695 - Disclosure - Nature of Business, Basis of Presentation and Segment Information - Summary of Cash Payment Due Under Financial Instruments (Detail) Sheet http://karyopharm.com/20260630/taxonomy/role/DisclosureNatureOfBusinessBasisOfPresentationAndSegmentInformationSummaryOfCashPaymentDueUnderFinancialInstrumentsDetail Nature of Business, Basis of Presentation and Segment Information - Summary of Cash Payment Due Under Financial Instruments (Detail) Details 33 false false R34.htm 995705 - Disclosure - Nature of Business, Basis of Presentation and Segment Information - Schedule of Revenue and Expense Categories in Single Operating Segment (Detail) Sheet http://karyopharm.com/20260630/taxonomy/role/DisclosureNatureOfBusinessBasisOfPresentationAndSegmentInformationScheduleOfRevenueAndExpenseCategoriesInSingleOperatingSegmentDetail Nature of Business, Basis of Presentation and Segment Information - Schedule of Revenue and Expense Categories in Single Operating Segment (Detail) Details 34 false false R35.htm 995715 - Disclosure - Product Revenue - Summary of Product Revenue (Details) Sheet http://karyopharm.com/20260630/taxonomy/role/DisclosureProductRevenueSummaryOfProductRevenueDetails Product Revenue - Summary of Product Revenue (Details) Details 35 false false R36.htm 995725 - Disclosure - Product Revenue - Additional Information (Detail) Sheet http://karyopharm.com/20260630/taxonomy/role/ProductRevenueAdditionalInformationDetail Product Revenue - Additional Information (Detail) Details 36 false false R37.htm 995735 - Disclosure - Inventory - Schedule of Inventory Current (Detail) Sheet http://karyopharm.com/20260630/taxonomy/role/InventoryScheduleOfInventoryCurrentDetail Inventory - Schedule of Inventory Current (Detail) Details 37 false false R38.htm 995745 - Disclosure - License Agreements - Schedule of License and Other Revenue (Detail) Sheet http://karyopharm.com/20260630/taxonomy/role/DisclosureLicenseAgreementsScheduleOfLicenseAndOtherRevenueDetail License Agreements - Schedule of License and Other Revenue (Detail) Details 38 false false R39.htm 995755 - Disclosure - License Agreements - Additional Information (Detail) Sheet http://karyopharm.com/20260630/taxonomy/role/DisclosureLicenseAgreementsAdditionalInformationDetail License Agreements - Additional Information (Detail) Details 39 false false R40.htm 995765 - Disclosure - Fair Value Measurements - Schedule of Financial Assets That Have Been Measured at Fair Value (Detail) Sheet http://karyopharm.com/20260630/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsThatHaveBeenMeasuredAtFairValueDetail Fair Value Measurements - Schedule of Financial Assets That Have Been Measured at Fair Value (Detail) Details 40 false false R41.htm 995775 - Disclosure - Fair Value Measurements - Additional Information (Detail) Sheet http://karyopharm.com/20260630/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail Fair Value Measurements - Additional Information (Detail) Details 41 false false R42.htm 995785 - Disclosure - Fair Value Measurements - Summary of the Changes in the Estimated Fair Value of the Liabilities (Detail) Sheet http://karyopharm.com/20260630/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfTheChangesInTheEstimatedFairValueOfTheLiabilitiesDetail Fair Value Measurements - Summary of the Changes in the Estimated Fair Value of the Liabilities (Detail) Details 42 false false R43.htm 995795 - Disclosure - Investments - Additional Information (Detail) Sheet http://karyopharm.com/20260630/taxonomy/role/InvestmentsAdditionalInformationDetail Investments - Additional Information (Detail) Details 43 false false R44.htm 995805 - Disclosure - Investments - Summary of Investments, Classified as Available-for-Sale (Detail) Sheet http://karyopharm.com/20260630/taxonomy/role/InvestmentsSummaryOfInvestmentsClassifiedAsAvailableForSaleDetail Investments - Summary of Investments, Classified as Available-for-Sale (Detail) Details 44 false false R45.htm 995815 - Disclosure - Net Loss Per Share - Additional Information (Detail) Sheet http://karyopharm.com/20260630/taxonomy/role/DisclosureNetLossPerShareAdditionalInformationDetail Net Loss Per Share - Additional Information (Detail) Details 45 false false R46.htm 995825 - Disclosure - Net Loss Per Share - Schedule of Reconciliation of the Numerator and Denominator Used to Calculate Diluted Net Loss per Common Share (Detail) Sheet http://karyopharm.com/20260630/taxonomy/role/DisclosureNetLossPerShareScheduleOfReconciliationOfTheNumeratorAndDenominatorUsedToCalculateDilutedNetLossPerCommonShareDetail Net Loss Per Share - Schedule of Reconciliation of the Numerator and Denominator Used to Calculate Diluted Net Loss per Common Share (Detail) Details 46 false false R47.htm 995835 - Disclosure - Net Loss Per Share - Schedule of Potentially Dilutive Securities were Excluded from the Calculation of Diluted Net Loss Per Share Due to Their Anti-Dilutive Effect (Detail) Sheet http://karyopharm.com/20260630/taxonomy/role/DisclosureNetLossPerShareScheduleOfPotentiallyDilutiveSecuritiesWereExcludedFromTheCalculationOfDilutedNetLossPerShareDueToTheirAntidi Net Loss Per Share - Schedule of Potentially Dilutive Securities were Excluded from the Calculation of Diluted Net Loss Per Share Due to Their Anti-Dilutive Effect (Detail) Details 47 false false R48.htm 995845 - Disclosure - Stock-based Compensation Expense - Schedule of Total Stock-based Compensation Expense Recognized in Connection with All Share-based Payment Awards (Detail) Sheet http://karyopharm.com/20260630/taxonomy/role/DisclosureStockbasedCompensationExpenseScheduleOfTotalStockbasedCompensationExpenseRecognizedInConnectionWithAllSharebasedPaymentAwardsDetai Stock-based Compensation Expense - Schedule of Total Stock-based Compensation Expense Recognized in Connection with All Share-based Payment Awards (Detail) Details 48 false false R49.htm 995855 - Disclosure - Stock-based Compensation Expense - Additional Information (Detail) Sheet http://karyopharm.com/20260630/taxonomy/role/DisclosureStockbasedCompensationExpenseAdditionalInformationDetail Stock-based Compensation Expense - Additional Information (Detail) Details 49 false false R50.htm 995865 - Disclosure - Stockholders' Equity - Additional Information (Detail) Sheet http://karyopharm.com/20260630/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetail Stockholders' Equity - Additional Information (Detail) Details 50 false false R51.htm 995875 - Disclosure - Long-Term Obligations - Additional Information (Detail) Sheet http://karyopharm.com/20260630/taxonomy/role/DisclosureLongtermObligationsAdditionalInformationDetail Long-Term Obligations - Additional Information (Detail) Details 51 false false R52.htm 995895 - Disclosure - Long-Term Obligations - Summary of Outstanding Balances of Amended Term Loan (Detail) Sheet http://karyopharm.com/20260630/taxonomy/role/DisclosureLongtermObligationsSummaryOfOutstandingBalancesOfAmendedTermLoanDetail Long-Term Obligations - Summary of Outstanding Balances of Amended Term Loan (Detail) Details 52 false false R53.htm 995905 - Disclosure - Long-Term Obligations - Schedule of Interest Expense Recognized Related to Term Loan and Amended Term Loan (Detail) Sheet http://karyopharm.com/20260630/taxonomy/role/DisclosureLongtermObligationsScheduleOfInterestExpenseRecognizedRelatedToTermLoanAndAmendedTermLoanDetail Long-Term Obligations - Schedule of Interest Expense Recognized Related to Term Loan and Amended Term Loan (Detail) Details 53 false false R54.htm 995915 - Disclosure - Long-Term Obligations - Summary of Future Minimum Payments on Amended Term Loan (Detail) Sheet http://karyopharm.com/20260630/taxonomy/role/DisclosureLongtermObligationsSummaryOfFutureMinimumPaymentsOnAmendedTermLoanDetail Long-Term Obligations - Summary of Future Minimum Payments on Amended Term Loan (Detail) Details 54 false false R55.htm 995925 - Disclosure - Long-Term Obligations - Summary of Outstanding Balances of New 2029 Notes (Detail) Notes http://karyopharm.com/20260630/taxonomy/role/DisclosureLongtermObligationsSummaryOfOutstandingBalancesOfNew2029NotesDetail Long-Term Obligations - Summary of Outstanding Balances of New 2029 Notes (Detail) Details 55 false false R56.htm 995935 - Disclosure - Long-Term Obligations - Summary of Outstanding Balances of 2028 Notes (Detail) Notes http://karyopharm.com/20260630/taxonomy/role/DisclosureLongtermObligationsSummaryOfOutstandingBalancesOf2028NotesDetail Long-Term Obligations - Summary of Outstanding Balances of 2028 Notes (Detail) Details 56 false false R57.htm 995955 - Disclosure - Long-Term Obligations - Schedule of Interest Expense Recognized Related to 2029 Notes and New 2029 Notes (Detail) Notes http://karyopharm.com/20260630/taxonomy/role/DisclosureLongtermObligationsScheduleOfInterestExpenseRecognizedRelatedTo2029NotesAndNew2029NotesDetail Long-Term Obligations - Schedule of Interest Expense Recognized Related to 2029 Notes and New 2029 Notes (Detail) Details 57 false false R58.htm 995965 - Disclosure - Long-Term Obligations - Summary of Future Minimum Payments on New 2029 Notes and 2028 Notes (Detail) Notes http://karyopharm.com/20260630/taxonomy/role/DisclosureLongtermObligationsSummaryOfFutureMinimumPaymentsOnNew2029NotesAnd2028NotesDetail Long-Term Obligations - Summary of Future Minimum Payments on New 2029 Notes and 2028 Notes (Detail) Details 58 false false R59.htm 995985 - Disclosure - Common Share Warrants - Additional Information (Detail) Sheet http://karyopharm.com/20260630/taxonomy/role/DisclosureCommonShareWarrantsAdditionalInformationDetail Common Share Warrants - Additional Information (Detail) Details 59 false false R60.htm 995995 - Disclosure - Common Share Warrants - Summary of Activity Related to our Common Stock Warrants (Details) Sheet http://karyopharm.com/20260630/taxonomy/role/DisclosureCommonShareWarrantsSummaryOfActivityRelatedToOurCommonStockWarrantsDetails Common Share Warrants - Summary of Activity Related to our Common Stock Warrants (Details) Details 60 false false R61.htm 996005 - Disclosure - Subsequent Event - Additional Information (Detail) Sheet http://karyopharm.com/20260630/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetail Subsequent Event - Additional Information (Detail) Details 61 false false R62.htm 996015 - Disclosure - Subsequent Event - 2025 Notes - Additional Information (Detail) Notes http://karyopharm.com/20260630/taxonomy/role/DisclosureSubsequentEvent2025NotesAdditionalInformationDetail Subsequent Event - 2025 Notes - Additional Information (Detail) Details 62 false false R63.htm 996025 - Disclosure - Subsequent Event - Senior Secured Term Loan - Additional Information (Detail) Sheet http://karyopharm.com/20260630/taxonomy/role/DisclosureSubsequentEventSeniorSecuredTermLoanAdditionalInformationDetail Subsequent Event - Senior Secured Term Loan - Additional Information (Detail) Details 63 false false R64.htm 996035 - Disclosure - Subsequent Event - 2029 Notes - Additional Information (Detail) Notes http://karyopharm.com/20260630/taxonomy/role/DisclosureSubsequentEvent2029NotesAdditionalInformationDetail Subsequent Event - 2029 Notes - Additional Information (Detail) Details 64 false false R65.htm 996045 - Disclosure - Subsequent Event - 2028 Notes - Additional Information (Detail) Notes http://karyopharm.com/20260630/taxonomy/role/DisclosureSubsequentEvent2028NotesAdditionalInformationDetail Subsequent Event - 2028 Notes - Additional Information (Detail) Details 65 false false R66.htm 996055 - Disclosure - Subsequent Event - Deferred Royalty Obligation - Additional Information (Detail) Sheet http://karyopharm.com/20260630/taxonomy/role/DisclosureSubsequentEventDeferredRoyaltyObligationAdditionalInformationDetail Subsequent Event - Deferred Royalty Obligation - Additional Information (Detail) Details 66 false false R67.htm 996065 - Disclosure - Subsequent Event - Common Shares and Common Share Warrants - Additional Information (Detail) Sheet http://karyopharm.com/20260630/taxonomy/role/DisclosureSubsequentEventCommonSharesAndCommonShareWarrantsAdditionalInformationDetail Subsequent Event - Common Shares and Common Share Warrants - Additional Information (Detail) Details 67 false false All Reports Book All Reports kpti-20260630.htm kpti-20260630.xsd http://fasb.org/us-gaap/2026 http://xbrl.sec.gov/dei/2026 http://xbrl.sec.gov/ecd/2026 false false